CA
NZ
UK
AU
IND
US
A wide set of healthcare and biotechnology names are trading near their 52-week highs after today's opening, as second-quarter earnings results land in rapid succession across the sector. The breadth of the move is the notable feature. Large-cap biotechnology, animal health, molecular diagnostics and …
Precigen (NASDAQ:PGEN) is a Germantown, Maryland-based biopharmaceutical company advancing next-generation gene and cell therapies to address serious diseases in immuno-oncology, autoimmune disorders, and infectious diseases. The company leverages proprietary precision technology platforms, including UltraCAR-T, AdenoVerse, ActoBiotics, and UltraVector, to design, engineer, and manufacture differentiated …
Septerna (NASDAQ:SEPN) is a clinical-stage biotechnology company headquartered in South San Francisco, California, pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by its proprietary Native Complex Platform. Founded in 2019 and formerly known as GPCR NewCo, the company …
Twist Bioscience (NASDAQ:TWST) is a South San Francisco-based synthetic biology company founded in 2013 that has developed a proprietary silicon-based DNA synthesis platform, enabling high-throughput, cost-effective manufacturing of synthetic DNA at unprecedented precision and scale. The company offers a broad portfolio of products and …
UroGen Pharma (NASDAQ:URGN) is a Princeton, New Jersey-based biotechnology company focused on developing and commercializing innovative solutions for urothelial and specialty cancers, leveraging its proprietary RTGel reverse-thermal hydrogel technology platform that enables sustained, site-specific delivery of chemotherapy agents. The company's commercial portfolio includes JELMYTO, …
ACADIA Pharmaceuticals (NASDAQ:ACAD) is a San Diego-based biopharmaceutical company focused on the development and commercialization of innovative medicines targeting central nervous system disorders and rare diseases in the United States. The company markets two FDA-approved products, NUPLAZID, the first and only approved treatment for …
Adaptive Biotechnologies (NASDAQ:ADPT), founded in 2009 and headquartered in Seattle, Washington, is a commercial-stage biotechnology company harnessing the biology of the adaptive immune system to transform disease diagnosis and treatment. The company operates through two core segments: Minimal Residual Disease Diagnostics, anchored by its …
Amgen (NASDAQ:AMGN) is a leading global biotechnology company founded in 1980 and headquartered in Thousand Oaks, California, dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics. Its extensive product portfolio spans oncology and hematology, inflammatory diseases, bone health, cardiovascular disease, nephrology, and neuroscience, …
AngioDynamics (NASDAQ:ANGO) is a medical technology company headquartered in Latham, New York, that designs, manufactures, and markets a broad range of minimally invasive, image-guided medical, surgical, and diagnostic devices used to treat peripheral vascular disease, support vascular access, and address oncology and surgical needs. …
BillionToOne (NASDAQ:BLLN) is a Menlo Park, California-based precision diagnostics company founded in 2016 by Dr. Oguzhan Atay and Dr. David Tsao, dedicated to making molecular diagnostics more powerful, efficient, and accessible. Its patented Quantitative Counting Templates platform is a proprietary molecular counting technology capable …
Please wait processing your request...